
These findings may offer more personalized treatment and prevention recommendations for patients with psoriasis.

These findings may offer more personalized treatment and prevention recommendations for patients with psoriasis.

About 43% of patients experienced complete depletion of B cells after the first round of rituximab, and those patients had greater odds of longer-term success.